Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
Open Access
- 24 February 2007
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 8 (1) , 15
- https://doi.org/10.1186/1465-9921-8-15
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Reversal of experimental pulmonary hypertension by PDGF inhibitionJournal of Clinical Investigation, 2005
- Imatinib for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2005
- Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary RevascularizationNew England Journal of Medicine, 2005
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Cell Cycle Protein Expression in Vascular Smooth Muscle Cells In Vitro and In Vivo Is Regulated Through Phosphatidylinositol 3-Kinase and Mammalian Target of RapamycinArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- Diffuse smooth muscle proliferation of the lungs with severe pulmonary hypertensionHuman Pathology, 1996
- Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media.Journal of Clinical Investigation, 1995
- Vasoconstriction and Medial Hypertrophy in Pulmonary HypertensionCirculation, 1960